Searched for
AFFORDABLE MEDICINES SUPPLIER
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- India’s pharma exports stay resilient amid global headwinds, near $29 billion markIndian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues ...
- Policy clarity helps protect pricing stability, ensure supply: Pharma companiesThe latest move would support pricing stability and supply continuity for one of India's top export items to America, even as both sides co...
- India's pharma exports cross $30 billion: Rajesh AgrawalIndia's pharmaceutical exports have surpassed $30 billion in FY25. The nation stands as a trusted global supplier of quality and affordable...
- Pharma exporters seek rollback of rule banning export of India-only drugsA new regulation by India's drug authority, restricting the export of pharmaceuticals labeled "For sale in India only," is causing signific...
- Trump tariffs to push up US drug prices, won’t change India’s pharma growth playbook: PharmexcilIndia’s pharma strategy is long-term and not reactive to tariffs, said Pharmexcil.
- Seen many models but India's is the best: Indonesia minister after visiting Jan Aushadhi KendraUnion Health Minister Mansukh Mandaviya led a G20 delegation to a 'Jan Aushadhi Kendra' in Gandhinagar to share India's success in providin...
- Many essential drugs priced much higher than manufacturing cost: WHOEven off patent drugs which are in the market for long and commonly used for diseases like HIV, tuberculosis and malaria are priced very hi...
- How PM Narendra Modi put new life in an ailing UPA schemeFew had heard of Jan Aushadhi Scheme before September 2015, when the Modi-led government renamed it first as Pradhan Mantri Jan Aushadhi Yo...
- Arvind Kejriwal warns of action over medicine crunch in hospitalsKejriwal has laid down the instruction in a letter to Chief Secretary M M Kutty on the issue that came to the fore during his recent surpri...
- 'Donald Trump's push for lower drug prices to benefit Indian pharma'A Glenmark spokesperson said Indian pharma companies are known to offer products at lesser prices and it will look to address the rising dr...
- Government to come out with revised strategy for 'Jan Aushadhi'The Centre is coming out with a revised strategy for 'Jan Aushadhi' scheme, which seeks to provide quality medicines at affordable price, t...
- Government revisiting 'Jan Aushadhi' scheme to expand reachThe minister said BPPI has prescribed certain norms for bidders and suppliers to ensure quality in medicine procurement.
- India rejects Abbot lab's patent application for HIV drugIndia has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
Load More
